Comparison of the immunologic profile between pleural effusion and cavitary parenchymal disease in young patients with pulmonary tuberculosis Source: Annual Congress 2009 - Tuberculosis at different age groups Year: 2009
Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019 Year: 2020
IL-6 and IL-8 in stable and exacerbated IPF patients and their association to outcome Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016
Systemic cytokine levels in community-acquired pneumonia and their association with disease severity Source: Eur Respir J 2002; 20: 990-995 Year: 2002
Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease Source: Eur Respir J, 51 (1) 1701578; 10.1183/13993003.01578-2017 Year: 2018
The comparison of the manifestation of systemic inflammation in patients with minor forms of tuberculosis and pulmonary sarcoidosis Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009
Utility of quantitative T-cell responses versus unstimulated interferon-gamma for the diagnosis of pleural tuberculosis Source: Eur Respir J 2009; 34: 1118-1126 Year: 2009
The impact of first symptoms on patient delay in pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 380s Year: 2006
Detection of IFN-γ responses for diagnosis of tuberculosis infection in chronic inflammatory disease patients Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011
The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013
Clinical utility of the interferon-gamma for the diagnosis of active pulmonary tuberculosis Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011
The influence of SARS-CoV-2 co-infection and active tuberculosis on the severity of the disease course and mortality. Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021
Impact of pulmonary tuberculosis infection on chronic obstructive pulmonary disease Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011
The delay from first symptom to definite diagnosis of pleural and pulmonary tuberculosis Source: Annual Congress 2010 - Extrapulmonary tuberculosis Year: 2010
The effect of anti-inflammatory treatment to the pleural thickening in tuberculosis pleuresy Source: Eur Respir J 2004; 24: Suppl. 48, 722s Year: 2004
The effect of pentoxifylline on IL-12 and IL-18 release by alveolar macrophages in sarcoidosis and hypersensitivity pneumonitis versus idiopathic pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 377s Year: 2003
Evaluation of inflammatory mediators of pleural effusion in tuberculosis and non-tuberculosis patients Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis Year: 2020
The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleuritis Source: Eur Respir J 2005; 26: Suppl. 49, 690s Year: 2005
Cytokine gene polymorphisms and mycobacterium tuberculosis : from infection to pulmonary disease Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection Year: 2006
Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011